Cargando…

A Full GMP Process to Select and Amplify Epitope-Specific T Lymphocytes for Adoptive Immunotherapy of Metastatic Melanoma

A number of trials of adoptive transfer of tumor-specific T lymphocytes have been performed in the last 20 years in metastatic melanoma, with increasingly encouraging results as the relevant melanoma antigens were identified and the purity/specificity of injected T cells improved. We have previously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labarriere, N., Fortun, A., Bellec, A., Khammari, A., Dreno, B., Saïagh, S., Lang, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806119/ https://www.ncbi.nlm.nih.gov/pubmed/24194775 http://dx.doi.org/10.1155/2013/932318

Ejemplares similares

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients
por: Dréno, Brigitte, et al.
Publicado: (2021)

Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
por: Zuliani, Thomas, et al.
Publicado: (2011)

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2018)

MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
por: Bobinet, Mathilde, et al.
Publicado: (2012)

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
por: Godet, Yann, et al.
Publicado: (2008)

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features
por: Simon, Sylvain, et al.
Publicado: (2018)

PD-1 expression conditions T cell avidity within an antigen-specific repertoire
por: Simon, Sylvain, et al.
Publicado: (2015)

Tissue Biomarkers in Melanoma Patients Treated with TIL
por: Knol, Anne-Chantal, et al.
Publicado: (2012)

Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
por: Saint-Jean, Mélanie, et al.
Publicado: (2020)

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival
por: Khammari, Amir, et al.
Publicado: (2014)

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018)

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
por: Herbreteau, Guillaume, et al.
Publicado: (2021)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
por: Krimphove, Marieke J., et al.
Publicado: (2019)

IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens
por: Charpentier, Maud, et al.
Publicado: (2016)

CD40L confers helper functions to human intra-melanoma class-I-restricted CD4(+)CD8(+) double positive T cells
por: Parrot, Tiphaine, et al.
Publicado: (2016)

Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases
por: L’Orphelin, Jean-Matthieu, et al.
Publicado: (2021)

hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote MELOE‐1 translation in stressed melanoma cells
por: Charpentier, Maud, et al.
Publicado: (2021)

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes
por: Marotte, L, et al.
Publicado: (2021)

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
por: Rabu, Catherine, et al.
Publicado: (2019)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
por: Mullinax, John E., et al.
Publicado: (2018)

Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2016)

Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.
por: Thatcher, N., et al.
Publicado: (1977)

GMP-production of purified human B lymphocytes for the adoptive transfer in patients after allogeneic hematopoietic stem cell transplantation
por: Tittlbach, Hannes, et al.
Publicado: (2017)

Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy
por: Zuliani, Thomas, et al.
Publicado: (2013)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
por: Rohaan, Maartje W., et al.
Publicado: (2018)

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma
por: Zoon, Christine Kathryn, et al.
Publicado: (2015)

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas
por: Desfrançois, Juliette, et al.
Publicado: (2010)

Proposal for an annual skin examination by a general practitioner for patients at high risk for melanoma: a French cohort study
por: Rat, Cédric, et al.
Publicado: (2015)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report
por: Quéreux, Gaelle, et al.
Publicado: (2017)

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma
por: Alvarez-Downing, Melissa M, et al.
Publicado: (2012)

Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma
por: Zhang, Ziyuan, et al.
Publicado: (2022)

CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy
por: Rotolo, Ramona, et al.
Publicado: (2019)

CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial
por: Poinas, Alexandra, et al.
Publicado: (2019)

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2
Publicado: (1984)

Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l17qlkffsprn367ht7rv7ln84i